share_log

UnitedHealth | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

UnitedHealth | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

聯合健康 | FWP:自由書寫募資說明書
美股SEC公告 ·  07/24 12:03
Moomoo AI 已提取核心訊息
UnitedHealth Group Incorporated has finalized a substantial issuance of notes on July 23, 2024, totaling $10.5 billion across various maturities ranging from 2026 to 2064. The offering includes $500 million in floating rate notes due in 2026, and fixed-rate notes with interest rates from 4.750% to 5.750% due between 2026 and 2064. The notes were priced close to their principal amounts and will yield slightly higher than corresponding U.S. Treasury benchmarks. UnitedHealth intends to use the net proceeds for general corporate purposes. The notes, registered under SEC No. 333-270279, will settle on July 25, 2024. The offering was managed by a syndicate of banks, including Wells Fargo Securities and Citigroup Global Markets, among others. UnitedHealth's notes received ratings of A2 from Moody's, A+ from S&P, and A from Fitch, indicating a strong credit profile.
UnitedHealth Group Incorporated has finalized a substantial issuance of notes on July 23, 2024, totaling $10.5 billion across various maturities ranging from 2026 to 2064. The offering includes $500 million in floating rate notes due in 2026, and fixed-rate notes with interest rates from 4.750% to 5.750% due between 2026 and 2064. The notes were priced close to their principal amounts and will yield slightly higher than corresponding U.S. Treasury benchmarks. UnitedHealth intends to use the net proceeds for general corporate purposes. The notes, registered under SEC No. 333-270279, will settle on July 25, 2024. The offering was managed by a syndicate of banks, including Wells Fargo Securities and Citigroup Global Markets, among others. UnitedHealth's notes received ratings of A2 from Moody's, A+ from S&P, and A from Fitch, indicating a strong credit profile.
聯合健康集團公司已於2024年7月23日完成了大規模債券發行,總額達105億美元,包括2026年至2064年不同到期期限的浮息債券總額5000萬美元,以及2026年至2064年的固定利率期貨,利率在4.750%至5.750%之間。這些債券的價格接近其本金金額,將比相應的美國國債基準略高。聯合健康打算將淨收益用於一般公司用途。這些債券在SEC No. 333-270279下注冊,並將於2024年7月25日結算。該發行由一家銀行業聯合體管理,包括富國證券和花旗環球市場等銀行。聯合健康的債券獲得穆迪的A2評級,標普的A +評級,和惠譽的A評級,表明其信用狀況良好。
聯合健康集團公司已於2024年7月23日完成了大規模債券發行,總額達105億美元,包括2026年至2064年不同到期期限的浮息債券總額5000萬美元,以及2026年至2064年的固定利率期貨,利率在4.750%至5.750%之間。這些債券的價格接近其本金金額,將比相應的美國國債基準略高。聯合健康打算將淨收益用於一般公司用途。這些債券在SEC No. 333-270279下注冊,並將於2024年7月25日結算。該發行由一家銀行業聯合體管理,包括富國證券和花旗環球市場等銀行。聯合健康的債券獲得穆迪的A2評級,標普的A +評級,和惠譽的A評級,表明其信用狀況良好。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息